Onward Medical N.V. (EBR:ONWD)
Belgium · Delayed Price · Currency is EUR 4.320
-0.025 (-0.58%)
Jul 18, 2025, 5:35 PM CET
Onward Medical Company Description
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI).
The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement.
It operates in France, Germany, the Netherlands, the United Kingdom, and Switzerland. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V.
| Country | Netherlands |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 103 |
| CEO | David Marver |
Contact Details
Address: Schimmelt 2 Eindhoven, NL-5611 Netherlands | |
| Website | onwd.com |
Stock Details
| Ticker Symbol | ONWD |
| Exchange | Euronext Brussels |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | NL0015000HT4 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David L. Marver | Chief Executive Officer and Executive Director |
| Dr. Gregoire Courtine Ph.D. | Chief Scientific Officer and Director |
| Amori Fraser | Senior Finance Director |
| Robert W. Odell | Vice President of Operations |
| Lorenzo Fanti | Vice President of Legal |
| Sebastien Cros | Vice President of Communications |
| Alexandre Casteau | Head of Strategy and Corporate Development |
| Mark Landman | Vice President of Sales |
| Sean Sciara | Vice President of Marketing |
| Julie Crom | Director of People and Culture |